Maplight Therapeutics (NASDAQ: MPLT) amends Form 144/A listing 3 RSU grants

Rhea-AI Filing Summary

Maplight Therapeutics, Inc. files an amendment to a Form 144/A detailing resale-related items tied to employee Restricted Stock Unit grants. The amendment lists 3,200 RSUs dated 07/30/2023, 1,434 RSUs dated 11/09/2023, and 6,147 RSUs dated 05/02/2024. The broker is listed as Jefferies LLC, the filing shows 04/15/2026, and the market noted is NASDAQ.

Key Figures

Filing date: 04/15/2026 Market: NASDAQ RSU grant (07/30/2023): 3,200 shares +2 more

5 metrics

Filing date 04/15/2026 Amendment header date

Market NASDAQ Trading venue listed in securities information

RSU grant (07/30/2023) 3,200 shares Restricted Stock Unit Grant dated 07/30/2023

RSU grant (11/09/2023) 1,434 shares Restricted Stock Unit Grant dated 11/09/2023

RSU grant (05/02/2024) 6,147 shares Restricted Stock Unit Grant dated 05/02/2024

Key Terms

Restricted Stock Unit Grant, Form 144/A, Jefferies LLC

3 terms

Restricted Stock Unit Grant financial

"Restricted Stock Unit Grant | Maplight Therapeutics, Inc."

Form 144/A regulatory

"144/A: Filer Information"

Jefferies LLC other

"Jefferies LLC 520 Madison Avenue 4th Floor New York NY 10022"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK
Filer CCC
Previous Accession Number Of The Filing
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Jefferies LLC 520 Madison Avenue 4th Floor New York NY 10022	4896	132289.92	42440000	04/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/30/2023	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			3200	07/30/2023	N/A
Common	11/09/2023	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			1434	11/09/2023	N/A
Common	05/02/2024	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			6147	05/02/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Nothing to Report

144/A: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Maplight Therapeutics' (MPLT) Form 144/A amendment report?

It reports resale-related details tied to specific Restricted Stock Unit grants. The amendment lists 3,200, 1,434, and 6,147 RSUs dated 07/30/2023, 11/09/2023, and 05/02/2024.

Who is the broker listed on MPLT's Form 144/A amendment?

The filing names Jefferies LLC as the broker. The broker address appears as 520 Madison Avenue, New York, NY 10022 in the amendment record.

When was the Form 144/A amendment for MPLT submitted?

The amendment shows a filing date of 04/15/2026. That date is the one recorded on the amendment's header information.

Which market does the MPLT amendment reference for potential resale?

The amendment lists NASDAQ as the market. The filing associates the resale-related entries with NASDAQ in the securities information.

Are the listed RSU grant dates included in the amendment for MPLT?

Yes. The amendment includes the grant dates: 07/30/2023, 11/09/2023, and 05/02/2024 linked to the corresponding RSU counts of 3,200, 1,434, and 6,147.